Table 1.
Drug | A—RR50 | A—MPC | B—RR50 | B—MPC | C—RR50 | C—MPC |
---|---|---|---|---|---|---|
10 | 0.503 ± 0.322 | 0.367 ± 0.308 | 0.507 ± 0.323 | 0.352 ± 0.303 | 0.509 ± 0.346 | 0.231 ± 0.268 |
20 | 0.293 ± 0.297 | 0.133 ± 0.205 | 0.295 ± 0.298 | 0.115 ± 0.194 | 0.189 ± 0.256 | 0.025 ± 0.082 |
30 | 0.088 ± 0.161 | 0.019 ± 0.061 | 0.081 ± 0.156 | 0.014 ± 0.054 | 0.022 ± 0.079 | 0.000 ± 0.004 |
40 | 0.010 ± 0.035 | 0.001 ± 0.005 | 0.008 ± 0.031 | 0.001 ± 0.002 | 0.000 ± 0.001 | 0.000 ± 0.000 |
50 | 0.000 ± 0.005 | 0.000 ± 0.000 | 0.000 ± 0.001 | 0.000 ± 0.000 | 0.000 ± 0.000 | 0.000 ± 0.000 |
A, clinically reported seizures with electrographic confirmation; B, all clinically reported events; C, all electrographically confirmed seizures; RR50, 50% responder rate, tested with Fisher's exact test; MPC, median percentage change, tested with the Wilcoxon rank‐sum test.